Lab Exit, Sale & Transition Planning
Laboratory Exit Planning for Lab Closures, Sales, and Facility Transitions
pForm helps plan and execute lab exits where equipment, facility contents, decontamination status, buyer interest, landlord timelines, removal logistics, and sale strategy all need to be coordinated — not handled as separate, disconnected problems.
→Whole-lab and equipment sale strategy
→Asset inventory and valuation
→Inspection and buyer-readiness documentation
→Decontamination and closeout coordination
→Confidential buyer marketing
→Removal and logistics coordination
When it comes up
When Labs Need an Exit Plan
- →Company shutdown
- →Funding loss
- →Relocation
- →Consolidation
- →M&A cleanup
- →Lease expiration
- →Clinical lab closure
- →Biotech or pharma downsizing
- →University / research lab transition
- →Receivership or distressed asset situation
Why one plan
One Plan for Assets, Sale Strategy, Closeout, and Removal
Lab exits fail when equipment sale, decontamination, waste removal, logistics, landlord deadlines, and buyer communication are each handled separately with no central plan. A missed decon step blocks removal. A removal scheduled before a sale closes loses a buyer. A landlord deadline nobody tracked against the sale timeline turns into holdover costs. pForm's lab exit planning brings all of it under one coordinated plan, sequenced against your actual deadline.
Sale strategy
Sale Path Options
There is no single best path for every lab exit. The right combination depends on the asset mix, your timeline, and what you're optimizing for.
| Path | Best for | Advantages | Tradeoffs |
|---|---|---|---|
| Whole-lab sale | A buyer wants an existing operational footprint, in place. | Single transaction; turnkey appeal can command a premium from the right buyer. | Smaller buyer pool; pricing reflects a bulk-package view. |
| Equipment package sale | Bundled equipment without the full facility. | Faster than itemized resale; appeals to buyers furnishing a new space. | Typically below peak per-instrument value. |
| Targeted resale | High-value individual instruments with a known buyer audience. | Can realize the strongest price for in-demand equipment. | Slower; requires per-instrument buyer outreach. |
| Auction | Mixed inventory with several in-demand items. | Buyer competition drives price discovery. | Variable outcomes; requires a defined listing window. |
| Consignment through resale channels | Quality equipment where time allows for individual sale. | Higher realized value than bulk on most categories, including via mLab Supply. | Recovery happens over weeks-to-months; storage logistics required. |
| Direct purchase | A fast, predictable exit where certainty matters more than peak price. | Single payment, single removal window, minimal coordination. | Bulk price; below auction-best on in-demand instruments. |
| Liquidation / removal-first strategy | Lease deadlines that don't allow time for a sale process to fully play out. | Clears the site on schedule; protects against holdover costs. | Lower per-unit recovery in exchange for speed and certainty. |
Valuation
Asset Inventory and Valuation
A realistic recovery estimate starts with a complete inventory and weighs several reference points against each other:
Equipment list creation
Manufacturer, model, and quantity for every recoverable asset.
Photos and serial numbers
Documentation that lets buyers evaluate equipment without an in-person visit.
Condition notes
Working, untested, or parts-only status recorded for each item.
Service records
Available maintenance and calibration history collected where it exists.
Accessories / software / computer notes
What's included, what's missing, and any software or control-PC dependencies.
Fair market value
What comparable equipment realistically sells for in the current secondary market.
Orderly liquidation value
A more conservative estimate reflecting a structured sale within a defined timeframe.
Auction value
What competitive bidding tends to produce for in-demand, individually listed instruments.
Replacement-cost context
New-equipment pricing, used only as context — not as a basis for sale price.
Removal / logistics cost impact
Freight, rigging, and decontamination costs that affect net recovery.
Inspection
Lab Inspection and Buyer-Readiness Review
- →Asset verification
- →Visible condition documentation
- →Decon status documentation
- →Equipment removability
- →Missing parts or accessories
- →Buyer-facing asset schedules
- →Service record collection
- →Inspection-style documentation for sale planning
pForm can document and organize laboratory assets for sale and buyer due diligence. This is an asset documentation review — we do not perform regulatory compliance certification, environmental clearance, biosafety certification, engineering inspection, or contamination clearance unless performed by qualified professionals.
Closeout
Decontamination and Facility Closeout Coordination
- →Decontamination planning
- →Hazardous waste / vendor coordination
- →Biological material closeout
- →Chemical inventory and waste considerations
- →Biosafety cabinet / fume hood decon coordination
- →Landlord closeout requirements
- →Final removal sequencing
pForm may coordinate with qualified decontamination, environmental, hazardous waste, biosafety, rigging, and facility vendors where required. We do not directly perform regulated decontamination, hazardous waste disposal, environmental remediation, or regulatory clearance unless separately authorized, licensed, insured, and contracted to do so. See our laboratory decontamination coordination page for the dedicated process, or our compliance & risk approach for more detail.
Important boundaries
Lease, Business, Legal, and Regulatory Boundaries
pForm focuses on lab assets, sale strategy, documentation, buyer marketing, removal planning, and recovery coordination. We are not a real estate broker, business broker, attorney, regulatory consultant, or clinical lab compliance advisor.
Lease assignment or sublease, business sale, ownership transfer, real estate, CLIA/COLA/CAP or other accreditation, Medicare or payer enrollment, permits, legal or regulatory matters, and facility compliance matters are handled separately by the appropriate professionals and approved parties.
Any seller-reported business, lease, licensing, revenue, accreditation, or regulatory information is subject to independent buyer due diligence. Transferability of any lease, license, accreditation, payer enrollment, permit, business operation, or ownership interest is not guaranteed.
Who we work with
Lab Types Supported
- Biotech R&D
- Pharma
- Clinical diagnostic
- Molecular
- Analytical testing
- University / research
- Industrial / QC
- Cannabis / hemp testing
Process
pForm Lab Exit Process
Every exit plan runs through the same nine steps. The depth of each one scales with the size and complexity of the facility.
- 01
Initial exit review
A conversation to understand why you're exiting, your timeline, and the scope of the facility and equipment.
- 02
Facility timeline and stakeholder review
Mapping lease, landlord, board, or creditor deadlines against the realistic sale and closeout timeline.
- 03
Asset inventory and document collection
Equipment list, photos, manufacturer/model data, and any available service records.
- 04
Valuation and sale-channel strategy
A recovery estimate and recommendation across whole-lab, equipment package, targeted resale, auction, consignment, or direct purchase.
- 05
Inspection / buyer-readiness review
Condition documentation and buyer-facing asset schedules built from the inventory.
- 06
Decon and closeout planning where needed
Sequencing decontamination, hazardous-material closeout, and removal logistics against the facility deadline.
- 07
Buyer marketing, auction, resale, or liquidation execution
Running the selected sale-channel strategy, including confidential buyer outreach where appropriate.
- 08
Removal, pickup, shipping, or transition coordination
Coordinated logistics through to a documented closeout, aligned with your lease or transition deadline.
- 09
Final reporting and recovery summary
A closeout report covering disposition records and the realized recovery breakdown.
Why pForm
Why pForm
Lab equipment resale knowledge
We understand which instrument categories hold value and how buyers evaluate them.
Asset recovery experience
Structured recovery programs across laboratory, biotech, pharma, and industrial equipment.
mLab Supply resale channel
Recovered equipment can be evaluated and listed through our partner marketplace for pre-owned lab instrumentation.
Whole-lab sale strategy
We evaluate whether a complete package sale fits, alongside individual equipment paths.
Auction / liquidation fallback
A built-in fallback if a whole-lab or targeted sale doesn't close in your timeline.
Inspection and documentation process
Buyer-ready asset schedules built from a consistent inspection and documentation process.
Decon / removal coordination awareness
We understand the decontamination and removal sequencing that affects timing and access.
Confidential seller process
NDA-gated buyer access and de-identified listing packages by default.
Support across stakeholders
We work with owners, operators, finance teams, landlords, and receivers — not just one type of seller.
FAQ
Laboratory exit planning — frequently asked questions
What is laboratory exit planning?+
Laboratory exit planning is the coordinated process of closing, selling, relocating, or transitioning a lab facility — bringing equipment sale strategy, asset valuation, decontamination and closeout planning, buyer marketing, and removal logistics under one plan instead of handling each piece separately and reactively.
When should a lab start planning its closure or sale?+
As early as possible — ideally as soon as a shutdown, relocation, consolidation, or sale decision is being considered, even before it's announced. Starting early gives you more sale-channel options, more time for buyer marketing, and more room to sequence decontamination and removal against your actual deadline rather than a compressed one.
Can pForm help sell the entire lab?+
Yes. A whole-lab package sale is one of several paths we evaluate, alongside equipment package sale, targeted resale, auction, consignment, and direct purchase. See our whole-lab sale options for the dedicated process.
Is liquidation better than a whole-lab sale?+
Not universally. A whole-lab sale can realize a premium when a buyer wants a turnkey operational footprint. Liquidation — auction, consignment, or targeted resale of individual equipment — often realizes more for high-demand instruments specifically. Most exit plans run a whole-lab marketing effort in parallel with a liquidation fallback so the timeline isn't put at risk.
Can pForm inspect and document the equipment?+
Yes. We can document and organize laboratory assets for sale and buyer due diligence — condition, photos, major-equipment identification, missing accessories, and available service records. This is an asset documentation review, not a regulatory compliance certification, environmental clearance, biosafety certification, or engineering inspection.
Does lab equipment need to be decontaminated before sale or removal?+
Many lab assets — particularly those exposed to biological, chemical, or radiological materials — need decontamination before sale or removal, and buyers increasingly expect documentation of it. We help plan and coordinate decontamination through qualified vendors; we do not perform regulated decontamination ourselves.
Can pForm handle hazardous waste or biological materials?+
We coordinate with qualified hazardous waste, environmental, and biosafety vendors where needed and help sequence that work against your sale and removal timeline. We do not directly perform regulated hazardous waste disposal, environmental remediation, or biological material destruction — that work must be performed by separately authorized, licensed, and insured vendors.
Can pForm help with lease, business, or ownership transfer?+
No — those are separate matters. Lease assignment or sublease, business sale, ownership transfer, real estate, CLIA/COLA/CAP or other accreditation, Medicare or payer enrollment, and permits must be handled by the appropriate parties and qualified professionals. We focus on lab assets, sale strategy, documentation, buyer marketing, removal planning, and recovery coordination. Any business, lease, licensing, revenue, accreditation, or regulatory information referenced during a process is seller-reported and subject to independent buyer due diligence. Transferability is never guaranteed.
Can pForm keep the process confidential?+
Yes. Whole-lab and equipment sale processes typically run through a confidential listing approach — de-identified asset details and photos — with an NDA required before identifying information or facility access is shared with a prospective buyer.
What happens if no buyer wants the full lab package?+
We build a fallback into the plan from the start. If no qualified whole-lab buyer emerges within an agreed window, the plan shifts to equipment package sale, targeted resale, auction, or consignment so the exit stays on schedule.
Newsletter
Lab Asset Market Brief
Weekly biotech, pharma, and lab asset updates. One short brief.
Planning a Lab Closure, Sale, or Transition?
The earlier you start, the more sale-channel options and recovery value you keep on the table. Tell us about your facility and timeline, and we'll outline an exit plan.